Company intelligence
ACTO
AI-Powered Intelligent Field Excellence for Life Sciences
About ACTO
ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and Marketing teams improve customer engagement and brand performance. With ACTO, #Biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness.
Verified activity
Signals from ACTO
9 published signals
Presence & Recognition
ACTO is sponsoring the Medical Affairs Technology and Innovation Symposium on October 15 in Boston.
Reported by ACTO
Presence & Recognition
ACTO is attending the Fiercest Week in Pharma in Philadelphia from September 14 to 17th.
Reported by ACTO
Presence & Recognition
ACTO CEO Parth Khanna is attending the live debate Beyond the Rep: What Will the Field Force Look Like in 2030 on Wednesday, September 16.
Reported by ACTO
Legal & Regulatory
ACTO achieved Veeva Gold Product Partner status as the only Life Sciences Field Excellence and Learning platform to hold this distinction.
Reported by ACTO
Presence & Recognition
ACTO is hosting the Fierce Pharma Week event in Philadelphia with a booth in Hall E, Booth 508.
Reported by Dan Henry
Partnerships
ACTO has been appointed as one of Veeva Systems' 130 Product Partners.
Reported by Alison Muller
Partnerships
ACTO has officially achieved Veeva Gold Partner status after nearly a decade of collaboration between ACTO and Veeva.
Reported by JoJo Kalita
Presence & Recognition
ACTO CEO Parth Khanna spoke with Pharmaceutical Executive about the importance of both AI compliance and capability in AI implementations.
Reported by ACTO
Research & Knowledge
ACTO CEO and Co-founder Parth Khanna explores how L&D teams react to barriers like administrative work, agency dependence, governance constraints, and pressure to prove impact in Part 2 of The New Era of Learner Empathy
Reported by ACTO